The study, released on bioRxiv, found that J&J’s shot produced roughly five-fold lower levels of antibodies against Delta strain compared to levels raised against an early strain.
J&J said the recipients of its vaccine produced strong neutralising antibodies over the course of at least eight months against all variants, including Delta.
This comes after the US Supreme Court refused to consider J&J’s objections to a 2018 jury finding. The company still faces more than 25,000 lawsuits blaming baby powder for causing cancers.
In late March, workers at a biodefence plant in Baltimore accidentally mixed ingredients of Johnson & Johnson and AstraZeneca vaccines, contaminating 15 million doses.
More than than 8 million Americans have been given J&J’s vaccine, which was haulted after a number of cases of blood clots emerged, especially in young women.
The decision comes at a crucial juncture in the US's vaccination effort, which has gained speed in recent weeks at the same time a worsening outbreak grips the upper Midwest.
President Joe Biden described the approval as an encouraging development in efforts to end the Covid-19 crisis and said this is exciting news for all US citizens.
In Episode 1544 of CutTheClutter, Editor-in-Chief Shekhar Gupta looks at some top economists pointing to the pitfalls of ‘currency nationalism’ with data from 1991 to 2004.
The decorated Naga officer from Manipur also served as envoy to Myanmar & Nagaland chief secy. Defence Minister Rajnath Singh inaugurated a museum dedicated to the Tawang hero Thursday.
Congress is silently acknowledging it over-read verdict of last general election. You can see it in easy concession to SP. It will likely be more reasonable in Maharashtra & Jharkhand.
COMMENTS